Congress extends diabetes funding for Native American communities through 2030
H.R. 5488 — Special Diabetes Program for Indians Reauthorization Act of 2025 · Filed by Raul Ruiz (D-CA) · 6 cosponsors · Introduced Sep 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill extends federal funding for the Special Diabetes Program for Indians by authorizing $160 million per year for fiscal years 2026–2030. The program provides diabetes prevention, treatment, and management services to American Indian and Alaska Native communities. The bill simply adds a new funding line to existing law without changing the program's structure or eligibility.
Why we flagged it
The bill is a straightforward extension of an existing federal health program serving a specific population. It adds funding authority without structural change, making it a routine reauthorization measure.
Who it affects
American Indian and Alaska Native communities, who experience disproportionately high rates of diabetes, retain access to federally funded prevention and treatment services. The authorization ensures continuity of care and health equity for a historically underserved population.
Who stands to gain
- Indian Health Service providers
- tribal health organizations
- community health centers serving Native populations
Named in the bill
Special Diabetes Program for Indians, Public Health Service Act, Section 330C, Indian Health Service, American Indian and Alaska Native communities
Where it stands
6 cosponsors: 4 Democrats, 2 Republicans.
- Sep 18, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 18, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Dec 2025 to Dec 2025. Those filings disclosed $290,000 in lobbying spend. A filing names 7 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Raul Ruiz, the sponsor, reported $1,028,105 in PAC receipts in the 2026 cycle.
- Breakthrough T1d (formerly Known As Jdrf Intl.) — $290,000 on 1 filing
Lobbying Disclosure Act filings through Jan 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (499 characters) on Jul 2, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Dec 2025. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jan 20, 2026 · page rendered 2026-10-20.
“Congress extends diabetes funding for Native American communities through 2030” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5488 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.